Characterization of cholyl-leu-val-phe-phe-ala-OH as an inhibitor of amyloid beta-peptide polymerization. (Q53350370)

13 May 2018

title

Characterization of cholyl-leu-val-phe-phe-ala-OH as an inhibitor of amyloid beta-peptide polymerization. (English)

1 reference

13 May 2018

author name string

Findeis MA

1

1 reference

13 May 2018

Lee JJ

2

1 reference

13 May 2018

Kelley M

3

1 reference

13 May 2018

Wakefield JD

4

1 reference

13 May 2018

Zhang MH

5

1 reference

13 May 2018

Chin J

6

1 reference

13 May 2018

Kubasek W

7

1 reference

13 May 2018

Molineaux SM

8

1 reference

13 May 2018

publication date

1 December 2001

1 reference

13 May 2018

published in

Amyloid

1 reference

13 May 2018

volume

8

1 reference

13 May 2018

issue

4

1 reference

13 May 2018

page(s)

231-241

1 reference

13 May 2018

Modified-peptide inhibitors of amyloid beta-peptide polymerization

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Alzheimer's disease: genotypes, phenotypes, and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Inhibition of amyloid formation: a strategy to delay the onset of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Translating cell biology into therapeutic advances in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Cognitive enhancement therapy for Alzheimer's disease. The way forward

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Therapeutic approaches related to amyloid-beta peptide and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Familial amyloid polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Aggregation and disaggregation of senile plaques in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

Thioflavine T interaction with amyloid β-sheet structures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506120108993819

10.3109/13506120108993819

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

release_aoichmoey5fepjsmxpt2abf2o4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/aoichmoey5fepjsmxpt2abf2o4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

13 May 2018